- Generic name
- Rivaroxaban
- Strength
- 2.5 mg
- Dosage form
- Tablet
- Manufactured by
- The ACME Laboratories Ltd.
RIVARA 2.5 Tablet
About RIVARA 2.5 Tablet
RIVARA 2.5 2.5 mg is a tablet product of The ACME Laboratories Ltd. that contains Rivaroxaban. RIVARA 2.5 is used in adults to lower the risk of stroke and systemic embolism in nonvalvular atrial fibrillation, and in the treatment of deep vein thrombosis and pulmonary embolism.
There are 19 brands of Rivaroxaban listed in Bangladesh. The lowest listed price is Rivadel 2.5 Tablet at ৳ 5 per unit.
What is RIVARA 2.5 Tablet?
RIVARA 2.5 is a tablet from The ACME Laboratories Ltd., with the generic name Rivaroxaban. Doctors prescribe it in adults for particular heart and blood vessel conditions where clots are a concern. Because this medicine affects clotting, it should only be taken on a doctor's advice, and the doctor chooses the dose and how long it is used. The dose and course are set by the doctor.
Uses of RIVARA 2.5
RIVARA 2.5 is used in adults to lower the risk of stroke and systemic embolism in nonvalvular atrial fibrillation, and in the treatment of deep vein thrombosis and pulmonary embolism. RIVARA 2.5 is used in adults after an acute coronary syndrome where cardiac biomarkers are raised, to help prevent atherothrombotic events. Do not start or stop treatment on your own. Your doctor will decide if it is suitable for you.
How to use RIVARA 2.5
RIVARA 2.5 is a tablet that is swallowed. RIVARA 2.5 is taken by mouth. Swallow the tablet with water. The doctor decides the dose, how often to take it and how long the course lasts. Do not stop, skip or change the medicine on your own, since stopping suddenly can raise the risk of clotting problems.
Side effects of RIVARA 2.5
Call your doctor promptly if you notice unusual or prolonged bleeding, or any sign of neurological problems such as weakness or numbness. More serious bleeding can occur, including bleeding in the spine or brain, and there is an increased risk of stroke if the medicine is stopped suddenly in people with nonvalvular atrial fibrillation. The most common side effect of Rivaroxaban is a greater chance of bleeding, which may appear as bruising, nosebleeds or bleeding gums, or bleeding that is hard to stop. Ask your doctor or pharmacist about any other effects you notice while taking RIVARA 2.5.
Safety and precautions
It is a pregnancy category C medicine, and there are no adequate studies in pregnancy or breastfeeding, so tell your doctor if you are pregnant, planning pregnancy or breastfeeding. It must not be used by anyone with a known allergy to Rivaroxaban or the tablet's other ingredients, or with active pathological bleeding. Pregnant or breastfeeding women, and anyone with kidney or liver problems, should speak to a doctor before use. Keep out of reach of children.
Frequently asked questions
What is RIVARA 2.5 used for?
RIVARA 2.5 is used in adults to lower the risk of stroke and systemic embolism in nonvalvular atrial fibrillation, and in the treatment of deep vein thrombosis and pulmonary embolism. RIVARA 2.5 is used in adults after an acute coronary syndrome where cardiac biomarkers are raised, to help prevent atherothrombotic events.
How do I use RIVARA 2.5 correctly?
RIVARA 2.5 is a tablet that is swallowed. RIVARA 2.5 is taken by mouth.
What are the side effects of RIVARA 2.5?
Call your doctor promptly if you notice unusual or prolonged bleeding, or any sign of neurological problems such as weakness or numbness. More serious bleeding can occur, including bleeding in the spine or brain, and there is an increased risk of stroke if the medicine is stopped suddenly in people with nonvalvular atrial fibrillation.
Can I use RIVARA 2.5 in pregnancy or while breastfeeding?
It is a pregnancy category C medicine, and there are no adequate studies in pregnancy or breastfeeding, so tell your doctor if you are pregnant, planning pregnancy or breastfeeding. It must not be used by anyone with a known allergy to Rivaroxaban or the tablet's other ingredients, or with active pathological bleeding.
Indications
- For the prevention of atherothrombotic events in adult patients after an Acute Coronary Syndrome (ACS) with elevated cardiac biomarkers (Troponin or CK-MB). It is co-administered with Aspirin alone or with Aspirin plus Clopidogrel orTidopidine.
- For the prevention of atherothrombotic events in adult patients after an Acute Coronary Syndrome (ACS) with elevated cardiac biomarkers (Troponin or CK-MB). It is co-administered with Aspirin alone or with Aspirin plus Clopidogrel orTidopidine.
- To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
- Deep vein thrombosis (DVT) & pulmonary embolism (PE) and reduction in the risk of recurrence of DVT and of PE
- For the prophylaxis of DVT, which may lead to PE in patients undergoing knee or hip replacement surgery
Pharmacology
Dosage & Administration
- The recommended dose: 2.5 mg twice daily. Patients should also take a daily dose of 75-100 mg Aspirin or a daily dose of 75-100 mg Aspirin in addition to either a daily dose of 75 mg clopidogrel or a standard daily dose of ticlopidine.
- Nonvalvular Atrial Fibrillation: For patients with Creatinin Clearance >50 mL/min: 20 mg orally, once daily with the evening meal. For patients with Creatinin Clearance 15-50 ml/min: 15 mg orally, once daily with the evening meal.
- Treatment of DVT & PE: 15 mg orally twice daily with food for the first 21 days for the initial treatment of acute DVT or PE. After the initial treatment period, 20 mg orally once daily with food for the remaining treatment.
- Prevention in the risk of recurrence of DVT and of PE: 20 mg once daily with food.
- Prophylaxis of DVT following Hip replacement surgery: 10 mg once daily for 35 days.
- Prophylaxis of DVT following knee replacement surgery: 10 mg once daily for 12 days.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Overdose Effects
Storage Conditions
Alternative brands of Rivaroxaban
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.